Outcome of Board Meeting

PRIMO CHEMICALS PCL:SEC:2026:264 14.08.2026 B P DMh aS ui lmr aE o IbLz Saeim ti rJi e–tee e 4ed tj 0,e 0Fe ob 00rh t 1oy Towers N PB Balaa o nnt dt di rNo ara on -. (a K ECl )u S / ,1 rt l , Mao GC uc mk o B mE alox p cc lek –h ,x a , 4n 0g 0e 0o 0f India Ltd. Scrip Code: 506852 Scrip Code: PRIMO sub.: ORReeuggtcuuollaamttiieoo nno sf 3 ,02 B 0oo 1f 5a .trhde MSeEeBtiIn (Lgi shteinldg oOnb li1g4atthio Anusg aunsdt , D2is0c2lo6s- uDreisR celoqsuuirreem unednetsr) Dear Sir Pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Rtchoeenq cuCluirodemem dpe an ant tsy 1) 6 inR :3 e 5itgs u Hmla oet uioersnti,ns in,g t 2 eh0 re-1 ald5 li , a wo, ne h aw1s4o ctuhol Ad n sul iigdkueesr t eto,d in 2af0no2drm6 a, pycpooroumv tmh ea det n t tch hee ed f oBalto l oa1wr2d in:o 3gf0 : DHiroeucrtso rasn odf 1. RCfineoa_mnapcpaiapnlo yyi n eftoamrr e 2cn 0ot 2o n6fd -u2Mc7/tsin gK aabnra a &u dAits osfo ccioastet sA, Cccoosut nAticncgo uRnteacnotrsd sa so ft hteh eC Cosotm Apuadnityo rf oor f tthhee 2. 51;t Annual General Meeting of the Company will be held on 30th September1 2026 at 1R4e.g0i0s theor uorfs m tehmrobuegrhs Vaidnedo S Chaornef eTrreanncsinfegr (BVoCo)k so rw oitllh beer Acluodseiod Vfrisouma l 2 M 4the Sanesp t(eOmAbVeMr, ).2 T0h2e6 tO 30th September, 2026 for the purpose of Annual General Meeting. 3. In-Principle approval for preparation of Scheme of Amalgamation of Flow Tech Chemical? PInrtievramtee Ldiimariiteesd in(“ Fthloisw r eTgeachrd”): with Primo Chemicals Limited (“Primo”) and appointment of Tonh e5 tCho Amupgaunsyt, h2a0d2 r6e fcoer ivaecdq uthisei taiopnp orof vbaal flraonmce t h5e1 %sh sahreahreohldoeldrsin vgid oef tFhlorowu gThe cPho asntadl Bmaalkloet irte ma awinhionlgly o 1w %n esdta kseu tbos midaiakrey . TFhloew CTeocmhp itasn wy hiso lilny otwhen epdro scuebsssi doiaf aryc.quisition of the said Now, the internal management team of the Company has proposed the plan to merge / ap Cmr oo mapl pgo aas nme iead st et o A F ctlb ,o ew 2 0uT 1ne 3dc , e rh u r lti ena stko e mPn ar ii dmn e o a t hcp euc reros uru nda dan ent r tc o ae naw d iS t ohc t h hte ehm r e ae pa o ppf l ip cA alimc ba la ebl g lalae wm p sar , ot rio evn gis ui( lo a“Sn tiocsh n oe sf m t ahe ne d”) rCeogumlaptoarnyy rinecqluuidreinmge snimts.p lifTichaeti osna moef thise esxtrpueccttuerde ,t ore dpurcotvioidne o fm cuoltisptl eo f bceonmepfitlsia tnoc eths? & boupredreantio bnys l iaqnudid raetisoonu rocfe Fsl oowf F Tloewch T eucpho nle caodminpgle ttoio ng reoaf mteer crgoenrt,r ohla.ving direct access to the Upon due consideration of the rationale, commercial benefits and other relevant aspects othf et hper opproopsoesde cdo tnrasindsearcattiioonn, toth efo Brmoaurladt ee xap reSscsheedm iets ionf- pmrienrcgipelre / aaprrparnogveaml toe npt,r oscuebejde wcti ttho PRIMO CHEMICALS LIMITED PHONE : 0172-2801649-R65E0G, ISETMEARILE :D &IN CFOO@RPPROIMROACTHEEOM FICFAILCSE.I:N B AYCN INO:. 4L264-15 I0O. CSHE C1T97O5RP L3C1O-A03, C60H7 ANWDEIBGSAITREH : -1W 6W0W03.P0RIMOCHEMICALS.IN WORKS : NANGAL-UNA ROAD, NAYA NANGAL- 140126 Dlsl-r. ROPAR, PUNJAB, INDIA and conditional upon the prior completion by Primo of the acquisition of balance 51% of tTch oee nc dihs i s tbiu oee ncd so , o mfs eu tshb esa c rwtrib ahe nod sll aya cn toid ow nn pedadoi d cs- uuu mbpse eindq tisua,ir tyy i n sochflu aPdre irni mgc oa t,hp eiitn a S al uco pcf p oF lredl moawne cneT ta e rwc yhi th, S s htu ahc reeh t et Phruma rt cs h F aal no sdew A acg qr ue ise itm ioe n n ot f( “S10u0p%ple omf ethneta reyq uS itP y A sh” a), r ea n cd a pa itp ap l l oic f a Fb lole w l a Tw ecs h. , U thp eo in nt c eo rnm alp l met aio nan g o ef m tehnet sahmaalll gpalamcaet iboenf otoreg eththee Br owairtdh, faollr irtesl actoends didoecruamtioenn atsn,d areppporortvsa, lc, etrhtiefic Sactehse,m oep oinf iomnesr g ae nr o vath lue ar t miona taenriadl sa ca cos u m ntia ngy b ree p orertqsu/cireerdtif iu can td ee s r aanpdp lleicgaabll,e t al xa w as n, d in rc el gu ud lain tog r, y a s op ainpipolnicsa ab nl de, approved the appointment of various intermediaries involved in the proposed transaction teoinrftm esrsum c aeh nd m dia e crir oec nsh d aain tsit o nbmsaa anysk ebmres a , y r etr bqa eun misrea udc tt u iionan lly ca oadngvnri eseo ecr dtiso.,n lweigtha l athdev ispororsp oasnedd oStchheer mpero, foens sisouncahl Tsahnec Btioonasrd, fcuornthseern tnso, tepde rtmhaists tihoen sp, roobpsoesrevda tSiocnhse,m neo s-ohbajlel cbtieo nssu bajencdt tfoili nsgusc ha sa pmpraoyv albse, thrcereeq du sii ttr ooe crdsk /u leen xnd cde her a arnsp g,p eali scs,a atb hpl eep Slilca eaw cbu,l reii t,n i ectslhu ead niHn dog n t Eh’xbe cl ea h p aNp nr gao etivo Banl osaa lo rCdf ot ohmfe Ipn Badno iaya rL(d “aS, wEsh TBarl”irb)e ,u h tnhoaeld l Me(r“isNn iaCsn tLrd yT/ ”o o)r f, Corporate Affairs and other statutory, regulatory or governmental authorities. Tprheep Baroaatordry a sctceoprsd iinn grelyl aatuiotnh otrois tehde thpero pinotseernda Sl mchaenmaeg eams emnat yt ob tea knee cseuscsha pryre olrim eixnpaeryd ieanndt, sreucbejeipctt oaf lwaall yrse qtou isthitee sftoarteugtooriyn ga ncdo nrdeigtiuolnasto rayn da pthpero vfuarltsh aenr da ppplarcoev alt hoef Sthchee mBoea brde faonrde the Boardf or their consideration and approval. The disclosures as required under Regulation 30 of the SEBI Listing Regulations readw ith SJaEnBuI aMrays, te2r0 C2ir6cu,l arc noon.c SeErBnIi/nHgO t/4h9e/1 4/a14b(o7)v2e02 5a-CpFpDo-PinOtDm2/e1n/3t7i s62 /20e2n6c dloasteedd 3 0aths Annexure I, to this intimation. Kindly take the above on record. Please acknowledge receipt. Thanking you, Yours faithfully, For Primo Chemicals Limited SUGANDHA KUKREJA Company Secretary & Chief HR Officer Annexure- I I(nLfisotrimnga tOiobnlai gsa rtieoqnusai rendd uDnisdcelor Rseugreul aRtieoqn u3ir0e m- Peanrtts A)R oefg Pualartaio An so 2 f 0 S1c5h aenddu SleE IBII oI Mf aSsEteBrI Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026d ated January 30, 2026. Particulars Cost Auditor M/s Kabra & Associates Rapepaosionntm foern cth, raensgigen vaitzio.n, removal, Re-appointment dD Ae paa pt+ oeh i noo tfP m Ae e+p nh tpoowinlstementa nd term of D14a.t0e8 o.2f r0e2-6appointment: Brief profile (in case of appointment) TIte irsm oaf ACpopsoti nAtmcceonut: nFtinaanntcsfi airl mye easr t2a0b2lis6h-2e7d to pcroomvidpee tqeunatl iptyr osfeesrvsicioen walitshi n thteh eairs sirsetsapneccet ivoef Disclosureo f relationships between fNieoldt aspplicable directors (in case of appointment of a director).